Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents-Reference-Cited by-同舟云学术

Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents

Published:2022-11 Issue: Volume:242 Page:114682
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhao Zean,Liu Jin,Yuan Lin,Yang Zichao,Kuang Peihua,Liao Hui,Luo Jian,Feng Huancun,Zheng Fengxin,Chen Yongjun,Wu Ting,Guo Jiayin,Cao Ying,Yang Yang,Lin Cuiting,Zhang Qun,Chen Jianjun^ORCID,Pang Jianxin

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference63 articles.

1. Gout;Dalbeth,2021

2. Hyperuricemia and cardiovascular disease;Zhang;Curr. Pharmaceut. Des.,2019

3. Hyperuricemia and associated diseases;Becker;Rheum. Dis. Clin. N. Am.,2006

4. Uric acid and the kidney: urate transport, stone disease and progressive renal failure;Capasso;Curr. Pharmaceut. Des.,2005

5. On the loss of uricolytic activity during primate evolution--I. Silencing of urate oxidase in a hominoid ancestor;Friedman;Comp. Biochem. Physiol. B,1985

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents;European Journal of Medicinal Chemistry;2024-11

2. Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production;Chemico-Biological Interactions;2024-11

3. Discovery of a Potent and Orally Bioavailable Xanthine Oxidase/Urate Transporter 1 Dual Inhibitor as a Potential Treatment for Hyperuricemia and Gout;Journal of Medicinal Chemistry;2024-08-07

4. Dietary anthocyanins as natural phytochemicals for regulating hyperuricemia: Proposed intestinal flora, key enzyme activity, and anti-inflammatory pathways;Trends in Food Science & Technology;2024-08

5. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout;Expert Opinion on Drug Metabolism & Toxicology;2023-11-25